Anna Styrud

Chief Financial Officer at Diamyd Medical AB

Anna Styrud

Anna Styrud

Chief Financial Officer at Diamyd Medical AB

Biography

Ms. Anna Styrud is Chief Financial Officer at Diamyd Medical AB. She is on the Board of Directors at Cellaviva AB. Ms. Styrud was previously employed as Chief Financial Officer by Mertiva AB. She received her undergraduate degree from the University of Uppsala.

Overview
Career Highlights

Diamyd Medical AB
Mertiva AB

RelSci Relationships

55

Number of Boards

1

Birthday

1961

Age

57

Relationships
RelSci Relationships are individuals Anna Styrud likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman at NextCell Pharma AB

Relationship likelihood: Strong

Chief Executive Officer at Index Diagnostics AB

Relationship likelihood: Strong

Former Senior Director-Clinical Development at Diamyd Medical AB

Relationship likelihood: Strong

President & Chief Executive Officer at Diamyd Medical AB

Relationship likelihood: Strong

Chief Scientific Officer at Diamyd Medical AB

Relationship likelihood: Strong

Chairman at Blasieholmen Investment Group Seed AB

Relationship likelihood: Average

Chief Executive Officer at Essen-Möller Consulting

Relationship likelihood: Average

Principal Investigator at Diamyd Medical AB

Relationship likelihood: Average

Principal Investigator at Diamyd Medical AB

Relationship likelihood: Average

Director at Quiapeg Pharmaceuticals Holding AB

Relationship likelihood: Average

Paths to Anna Styrud
Potential Connections via
Relationship Science
You
Anna Styrud
Chief Financial Officer at Diamyd Medical AB
Education

Uppsala Universty is a world class research and educational institution in Sweden.

Career History
Chief Financial Officer
2010 - Current

Diamyd Medical AB engages in the development of pharmaceutical products for the treatment of diabetes. It develops vaccine to cure autoimmune diabetes. The firm also involves in investment in medical and stem cell technology. The company was founded by Anders Essen-Moller in 1996 and is headquartered in Stockholm, Sweden.

Chief Financial Officer
2010 - Prior

Mertiva AB engages in owning, managing, acquiring, and trading of securities and other properties. It has holdings in Protein Sciences Corporation and Mercodia AB. The company is headquartered in Danderyd, Sweden.

Treasurer
Prior

Vasakronan AB operates as a real estate development company. The firm owns, develops, and manages commercial properties. Its properties are situated in clusters and offer supplementary services to the tenants. Its business activities also include office and retail leasing, and green leases and green offices development. The company was founded in 1955 and is headquartered in Stockholm, Sweden.

Boards & Committees
Director
Prior

NextCell Pharma AB engages in the development of stem cell products. It specializes on treatment of diabetes and immunosuppression in kidney transplants. The company was founded by Mathias Svahn, Edvard Smith, Hans-Peter Torsten Ekre, and Lena Degling Wilkingsson on March 19, 2014 and is headquartered in Huddinge, Sweden.

Other Affiliations

Anna Styrud is affiliated with Diamyd Medical AB, Mertiva AB, Vasakronan AB, NextCell Pharma AB

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Anna Styrud. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Anna Styrud's profile does not indicate a business or promotional relationship of any kind between RelSci and Anna Styrud.